Parkinson disease death rates increased in US adults 65+ from 1999 to 2017

An observational analysis of US national vital statistics data examined trends in Parkinson disease mortality among adults aged 65 years and older from 1999 to 2017. The study reported age-adjusted death rates, which increased from 41.7 to 65.3 per 100,000 population over this period. No specific intervention, comparator, or sample size was reported. The data source was the National Vital Statistics System.

The main finding was an increase in the reported age-adjusted death rate for Parkinson disease. The analysis did not provide statistical measures such as confidence intervals or p-values to quantify the uncertainty around this trend. Safety, tolerability, and adverse event data were not reported, as this was a population-level mortality analysis.

Key limitations include the observational nature of the data, which cannot establish causation. The report does not account for potential changes in diagnostic practices, coding, or disease awareness over the nearly two-decade period. Funding sources and conflicts of interest were not reported.

For clinical practice, this analysis highlights a temporal trend in recorded Parkinson disease mortality in an older US population. The findings should be interpreted as descriptive of vital statistics patterns rather than evidence of changing disease biology or treatment effects. Clinicians should recognize that such observational data cannot explain the reasons behind the reported increase.